Two Sigma Investments’s Valion Bio VBIO Stock Holding History

Two Sigma Investments’s Portfolio VBIO Stock Details VBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-715	Closed	-$4.21K	–	3484
2024 Q4	$4.21K	Buy	+715	New	+$3.33K	﹤0.01%	3153

Other funds holding VBIO

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Investments's VBIO Position: Q1 2025 in Review

Two Sigma Investments sold out of Valion Bio (VBIO) in Q1 2025, closing a stake of 715 shares — an estimated $4.21K sold.

Two Sigma Investments first reported a position in VBIO in Q4 2024 and held it in 1 quarter. The position peaked at $4.21K in Q4 2024. 2 funds tracked by Wall St. Rank hold VBIO as of Q1 2025.

Two Sigma Investments reported no remaining Valion Bio position as of Q1 2025 after selling out during the quarter.
Two Sigma Investments sold 715 Valion Bio shares in Q1 2025, an estimated $4.21K.
Two Sigma Investments first reported a position in Valion Bio in Q4 2024 and held it in 1 quarter.
Two Sigma Investments's Valion Bio position peaked at $4.21K in Q4 2024.
2 funds tracked by Wall St. Rank held Valion Bio as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.